Safety of a New Surgical Method for Crohn's Disease on Biologics
Part of Digestive system clinical trials.
This study tests whether a special surgical technique (mesentery-embedding) is safe for people with Crohn's disease who need ileocolic surgery and are already on a biologic medication. It aims to see if this method can help reduce complications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have Crohn's disease confirmed by a biopsy.
- You have had surgery to remove the part of your intestine where the small and large intestines meet (ileocolic resection), and your doctor can check that area with a scope.
- You are currently on a biologic medicine (like infliximab, adalimumab, vedolizumab, ustekinumab, or risankizumab).
- You are not pregnant, breastfeeding, or a new mother.
- You are not taking part in another experimental treatment study.
- You can read, write, and understand French.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two ways to choose biologic (targeted) medicines after Crohn’s surgery to help stop Crohn’s from coming back in the bowel. It may help you avoid or delay repeat inflammation by adjusting treatment based on endoscopy findings.
This trial tests whether a specific type of bowel connection during Crohn’s surgery can lower the chances that the disease comes back. It may help people having their first ileocolonic (small-to-large bowel) surgery for certain Crohn’s complications.
This study looks at outcomes after children with Crohn’s disease have part of the bowel removed (ileo-cecal resection). It may help doctors improve post-surgery care, especially for preventing flare-ups in the months after surgery.
This study compares a medical treatment approach versus surgery for people with Crohn’s disease that causes narrowing (strictures) in the small intestine and blocking symptoms. It aims to see which approach works better in easing symptoms and preventing problems from the narrowing.
This trial compares two ways of reconnecting the bowel after removing diseased intestine in people with Crohn’s disease. The goal is to see which method works better for healing and short- and longer-term outcomes.
This study follows adults with Crohn’s disease who need surgery to remove the ileocecal area. It aims to better understand post-operative outcomes and what to expect after the operation.
Hear when a new Crohn Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.